All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Corporate BondsHigh grade and crossover bonds

AstraZeneca heads to euros for more acquisition funding


AstraZeneca, the UK drug maker, hit the euro market on Wednesday after printing $7bn across the Atlantic a day earlier. The borrower is building up funds to pay for its $39bn acquisition of US rival Alexion Pharmaceuticals.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree